|
|
|
|
HK Im, WB Im, BJ Hamilton, DB Carter and PF Vonvoigtlander
Upjohn Company, Kalamazoo, Michigan 49001.
Previous studies with cloned gamma-aminobutyric acid type A receptors expressed in human embryonic kidney cells have indicated that the alpha 1 beta 2 gamma 2 and alpha 1 gamma 2 (but not alpha 1 beta 2) subtypes have benzodiazepine sites. We found in this study that even the beta 2 gamma 2 subtype displays gamma-aminobutyric acid-induced Cl- currents that are potentiated by triazolam (a triazolobenzodiazepine). The maximal efficacy of the drug among the subtypes was highest with the alpha 1 beta 2 gamma 2 subtype, followed by the alpha 1 gamma 2 and beta 2 gamma 2 subtypes. These observations led us to compare the ability of several benzodiazepine site agonists of diverse chemical structures to potentiate Cl- currents with these subtypes. With the alpha 1 gamma 2 subtype, diazepam, alpidem, zolpidem, Cl-218872, zopiclone, U-79098 (an imidazoquinoxaline derivative), and U-90167 (a diimidazoquinazoline derivative) at 5 microM potentiated Cl- currents to essentially similar levels (slightly lower for a few ligands), compared with those with the alpha 1 beta 2 gamma 2 subtype. With the beta 2 gamma 2 subtype, the type 1 ligands zolpidem, alpidem, and Cl- 218872 showed no or very low levels of potentiation, whereas less selective ligands such as diazepam, zopiclone, U-78098, and U-90167 displayed levels of Cl- current potentiation comparable to those observed with the subtypes containing the alpha 1 and gamma 2 subunits. These data indicate that, in the presence of gamma 2, beta 2 may substitute for alpha 1 in forming the benzodiazepine site of limited sensitivity to the type 1 ligands. It appears that individual ligands for benzodiazepine sites have their own sets of interacting domains, which are distributed in alpha 1 and gamma 2, and the agonistic activity of type 1 ligands may be more dependent on the alpha 1- specific domains than is that of less selective ligands.
This article has been cited by other articles:
![]() |
S. K. Sullivan, R. E. Petroski, G. Verge, R. S. Gross, A. C. Foster, and D. E. Grigoriadis Characterization of the Interaction of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic, with the GABAA Receptor J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 537 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Fleck Molecular Actions of (S)-Desmethylzopiclone (SEP-174559), an Anxiolytic Metabolite of Zopiclone J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 612 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vicini, C. Ferguson, K. Prybylowski, J. Kralic, A. L. Morrow, and G. E. Homanics GABAA Receptor {alpha}1 Subunit Deletion Prevents Developmental Changes of Inhibitory Synaptic Currents in Cerebellar Neurons J. Neurosci., May 1, 2001; 21(9): 3009 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. J. Dunn, M. Davies, A. L. Muntoni, and J. J. Lambert Mutagenesis of the Rat alpha 1 Subunit of the gamma -Aminobutyric AcidA Receptor Reveals the Importance of Residue 101 in Determining the Allosteric Effects of Benzodiazepine Site Ligands Mol. Pharmacol., October 1, 1999; 56(4): 768 - 774. [Abstract] [Full Text] |
||||
![]() |
A. J. Boileau, A. M. Kucken, A. R. Evers, and C. Czajkowski Molecular Dissection of Benzodiazepine Binding and Allosteric Coupling Using Chimeric gamma -Aminobutyric AcidA Receptor Subunits Mol. Pharmacol., February 1, 1998; 53(2): 295 - 303. [Abstract] [Full Text] |
||||
![]() |
J. Amin, A. Brooks-Kayal, and D. S. Weiss Two Tyrosine Residues on the alpha Subunit Are Crucial for Benzodiazepine Binding and Allosteric Modulation of gamma -Aminobutyric AcidA Receptors Mol. Pharmacol., May 1, 1997; 51(5): 833 - 841. [Abstract] [Full Text] |
||||
![]() |
W. B. Im, J. F. Pregenzer, J. A. Binder, G. H. Dillon, and G. L. Alberts Chloride Channel Expression with the Tandem Construct of alpha6-beta2 GABA(A) Receptor Subunit Requires a Monomeric Subunit of alpha6 or [IMAGE]2 J. Biol. Chem., November 3, 1995; 270(44): 26063 - 26066. [Abstract] [Full Text] [PDF] |
||||